Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

New EMA product specific guidance (PSG) [BE/BA News]

posted by SMA – Europe, 2024-01-16 10:51 (330 d 19:54 ago) – Posting: # 23828
Views: 2,384
(edited on 2024-01-16 11:07)

Dear all

EMA has published two new PSGs:

Azacitidine powder for suspension for injection 25 mg/ml product-specific bioequivalence guidance (here)
Paliperidone palmitate depot suspension for injection (every 3 months) 175, 263, 350 and 525 mg product-specific bioequivalence guidance (here)

Consultations open until 2024-04-30

Complete thread:

New EMA product specific guidance (PSG)SMA 2024-01-16 09:51
- New EMA product specific guidance (PSG) dshah 2024-01-17 10:12

Admin contact
23,336 posts in 4,902 threads, 1,666 registered users;
39 visitors (0 registered, 39 guests [including 7 identified bots]).
Forum time: 06:46 CET (Europe/Vienna)

Biostatistician. One who has neither the intellect for mathematics
nor the commitment for medicine but likes to dabble in both. Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz